GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Total Debt per Share

XBiotech (STU:4XB) Total Debt per Share : €0.30 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is XBiotech Total Debt per Share?

€0.30 (As of Sep. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. XBiotech's Total Debt Per Share for the quarter that ended in Sep. 2024 was €0.30.

XBiotech Total Debt per Share Historical Data

The historical data trend for XBiotech's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XBiotech Total Debt per Share Chart

XBiotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

XBiotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.30 0.31 0.30

XBiotech Total Debt per Share Calculation

XBiotech's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+0.00)/30.44
=0.00

XBiotech's Total Debt Per Share for the quarter that ended in Sep. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+9.01)/30.48
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XBiotech Total Debt per Share Related Terms

Thank you for viewing the detailed overview of XBiotech's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

XBiotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Total Debt per Share
Comparable Companies
INMB ANNX XFOR TALS LBPH PBYI CTXR RVPH GALT ADAP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
XBIT:USA
Address
5217 Winnebago Lane, Austin, TX, USA, 78744
Website
http://www.xbiotech.com
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

XBiotech Headlines

No Headlines